IBR733 Cell Injection
IBR733-101
Phase 1 mab active
Quick answer
IBR733 Cell Injection for Acute Myeloid Leukemia is a Phase 1 program (mab) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Acute Myeloid Leukemia
- Phase
- Phase 1
- Modality
- mab
- Status
- active